Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.73 USD | +4.11% | -2.49% | -18.50% |
05-10 | UBS Adjusts Privia Health Group Price Target to $26.50 From $29, Maintains Buy Rating | MT |
05-09 | Transcript : Privia Health Group, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.50% | 2.15B | |
+18.07% | 83.07B | |
-29.60% | 70.89B | |
+3.59% | 28.32B | |
-7.77% | 17.73B | |
+2.00% | 17.43B | |
+0.75% | 15.64B | |
+7.55% | 13.46B | |
+7.64% | 12.82B | |
+69.41% | 12.69B |
- Stock Market
- Equities
- PRVA Stock
- News Privia Health Group, Inc.
- Privia Health Group Insider Sold Shares Worth $454,432, According to a Recent SEC Filing